Managing the Burden of Prurigo Nodularis: The Role of Emerging Therapies – An In the Clinic Activity
hosted byIntegrity Continuing Education Inc.Managing the Burden of Prurigo Nodularis: The Role of Emerging Therapies – An In the Clinic Activity is organized by Integrity Continuing Education Inc..
Release date: February 8, 2023
Expiration date: February 8, 2024
Program Overview:
prurigo nodularis (PN) is a chronic, debilitating cutaneous disease with limited treatment options that exerts significant disease burden on patients. More than half of patients (61%) report that itch exerts a great impact on sleep. For many patients with PN, there is also a high prevalence of psychiatric comorbidities such as depression and anxiety.
This activity is designed to improve knowledge of disease pathogenesis, increase diagnostic awareness, and examine emerging therapies and their potential role in treatment. Join expert faculty, Gil Yosipovitch, MD and Shawn G. Kwatra, MD, as they walk through two interactive case presentations, provide rationale for optimal management and treatment, and describe methods for integration in practice.
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
- Apply available evidence and criteria to identify common symptoms and associated cycles of quality of life impact to support earlier diagnosis of PN
- Identify known factors involved in the pathogenesis of PN
- Utilize available guidance for the treatment of patients with PN
- Evaluate clinical evidence supporting use of current and investigational agents for the management of PN
